A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses

Clinical trial NCT05741294 · COMPLETED

Trial details

NCT number: NCT05741294
Sponsor: Almirall, S.A.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Actinic Keratosis

Start date: 2023-01-20
Primary completion: 2024-01-19
Enrollment: 334

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.